Publications

2013

Touat L, Fournier C, Ramon P, Salleron J, Durocher A, Nseir S. Intubation-related tracheal ischemic lesions: incidence, risk factors, and outcome. Intensive Care Med. 2013 Apr;39(4):575-82.

S Chaouche-Mazouni, M-C Copin, P Lassalle, N Lebaili, A Cortot, A Scherpereel. M14K and M38K Malignant Pleural Mesothelioma Cell Lines Preserve the Same Claudin-based Phenotype in Vivo. In Vivo 2013; 27(2):227-32.

De Freitas N, Legendre B, Parmentier E, Scherpereel A, Tsicopoulos A, Mathieu D, Lassalle P. Identification of a 14 kDa endocan fragment generated by Cathepsin G, a novel circulating biomarker in patients patients with sepsis. Journal of Pharmaceutical and Biomedical Analysis 2013 Feb 9;78-79C:45-51.

Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, Pinet C, Jebrak G, Brinchault G, Court-Fortune I, Paillasseur JL, Roche N; INITIATIVES BPCO Scientific Committee. Impact of comorbidities on COPD-specific health-related quality of life. Respir Med. 2013 Feb;107(2):233-41.

Bouvry D, Mouthon L, Brillet PY, Kambouchner M, Ducroix JP, Cottin V, Haroche  J, Viallard JF, Lazor R, Lebargy F, Tazi A, Wallaert B, Smail A, Pellegrin JL, Nunes H, Amoura Z, Cordier JF, Valeyre D, Naccache JM; Groupe Sarcoïdose Francophone. Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J. 2013 Jan;41(1):115-22.

Catherinot E, Roux AL, Vibet MA, Bellis G, Ravilly S, Lemonnier L, Le Roux E,  Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, Gaillard JL, Wallaert B et al; OMA group. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros. 2013 Jan;12(1):74-80.

Gouilleux-Gruart V, Chapel H, Chevret S, Lucas M, Malphettes M, Fieschi C, Patel S, Boutboul D, Marson MN, Gérard L, Lee M, Watier H, Oksenhendler E, Just N et al; DEFI study group. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism  of the neonatal Fc receptor. Clin Exp Immunol. 2013 Feb;171(2):186-94.

Lino Cardenas CL, Henaoui IS, Courcot E, Roderburg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki F, Dewaeles E, Milosevic J, Maurizio J, Tedrow J, Marcet B, Lo-Guidice JM, Kaminski N, Barbry P, Luedde T, Perrais M, Mari B, Pottier N. miR-199a-5p Is Upregulated during Fibrogenic Response to Tissue Injury and Mediates TGFbeta-Induced Lung Fibroblast Activation by Targeting Caveolin-1.  PLoS Genet. 2013 Feb;9(2):e1003291.

Wibmer T, Berghmans T, Kropf-Sanchen C, Lafitte JJ, Rüdiger S, Paesmans M, Blanta I, Scherpereel A, Stoiber KM, Rottbauer W, Sculier JP, Schumann C. Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy. Lung. 2013 Jun;191(3):271-80.

Sobanski V, Ajzenberg D, Delhaes L, Bautin N, Just N. Severe toxoplasmosis in immunocompetent hosts: be aware of atypical strains. Am J Respir Crit Care Med. 2013 May 15;187(10):1143-5.

Tacelli N, Santangelo T, Scherpereel A, Duhamel A, Deken V, Klotz E, Cortot A, Lafitte JJ, Wallyn F, Remy J, Remy-Jardin M. Perfusion CT depicts early and specific changes in Tumor Vascularity and allows to predict therapy response in Non Small Cell Lung Cancer treated with conventional and anti-angiogenic chemotherapy. European Radiology 2013, 23:2127-36.

Habib S, Delourme J, Dhalluin X, Petyt G, Scherpereel A, Lafitte J-J, Cortot AB. Bevacizumab and weekly paclitaxel for non-squamous Non Small Cell Lung Cancer patients: a retrospective study. Lung Cancer 2013, 80: 196-202.

Gourcerol D, Scherpereel A, Debeugny S, Porte P, Cortot AB, Lafitte J-J. Relevance of an extensive follow-up after surgery for non-small cell lung cancer. Eur Respir J 2013 42(5):1357-64

F Barlesi, A Scherpereel, A Rittmeyer, A Pazzola, N Ferrer Tur, J-H Kim, M-J Ahn, J G.J.V. Aerts, V Gorbunova, A Vikström, EK. Wong, P Perez-Moreno, L Mitchell, and H J.M. Groen. A Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed Following First-Line Induction With Bevacizumab–Cisplatin–Pemetrexed in Advanced Nonsquamous Non–Small Cell Lung Cancer: AVAPERL (MO22089). J Clin Oncol 2013, 31: 3004-11.

Scherpereel A, Grigoriu BD, Noppen M, Gey T, Chahine B, Baldacci S, Trauet J,  Copin MC, Dessaint JP, Porte H, Labalette M. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid. BMC Cancer. 2013 Jul 2;13:324.

Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, Airo P, Matucci-Cerinic M, Wallaert B, Israel-Biet D, Cadranel J, Cottin V, Gazal S, Peljto AL, Varga J, Schwartz DA, Valeyre D, Grandchamp B. The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population. PLoS One. 2013 Aug 5;8(8):e70621.

Legendre B, Tokarski C, de Freitas caires N, Chang Y, Lortat-Jacob H, de Nadai P, Rolando C, Duez C, Tsicopoulos A, Lassalle P. The disulfide bond between cysteine 10 and cysteine 34 is required for CCL18 activity. Cytokine, 2013, 64:463-70.

Glineur C, Gross B, Neve B, Rommens C, Chew GT, Martin-Nizard F, Rodríguez-Pascual F, Lamas S, Watts GF, Staels B. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):621-8.

Pourcet B, Staels B, Glineur C. PPAR SUMOylation: some useful experimental tips. Methods Mol Biol. 2013;952:145-61.

Parmentier-Decrucq E, Poissy J, Favory R, Nseir S, Onimus T, Guerry MJ, Durocher A, Mathieu D. Adverse events during intrahospital transport of critically ill patients: incidence and risk factors. Ann Intensive Care. 2013 Apr 12;3(1):10.

Duburcq T, Parmentier-Decrucq E, Poissy J, Mathieu D. Pseudomembranous colitis due to Clostridium difficile as a cause of perineal necrotising fasciitis. BMJ Case Rep. 2013 Jan 22;2013.

Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S; MERS-CoV study group. Clinical features and viral  diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013 Jun 29;381(9885):2265-72.

A. Tsicopoulos, Y. Chang,  S. Ait Yahia, P. de Nadai, C. Chenivesse. Role of CCL18 in asthma and lung immunity, Clin Exp Allergy, 2013, 43:716-722.

A. Tsicopoulos, P de Nadai, C Glineur. Environmental and genetic contribution in airway epithelial barrier in asthma pathogenesis, Curr Opin Allergy Clin Immunol. 2013, 13: 495-499.

 

2012

Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, Cs Toth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert  AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, Van Schil P,  Wachters C, Westeel V, Sculier JP; ELCWP. Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations. Eur Respir J. 2012 Jan;39(1):9-28.

Borget I, Cadranel J, Pignon JP, Quoix E, Coudert B, Westeel V, Dansin E, Madelaine J, Madroszyk A, Friard S, Daniel C, Morin F, Chouaid C, Scherpereel A et al, ERMETIC Collaborative Group. Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3. Eur  Respir J. 2012 Jan;39(1):172-9.

Legroux-Gérot I, Leroy S, Prudhomme C, Perez T, Flipo RM, Wallaert B, Cortet B. Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers. Joint Bone Spine. 2012 Jan;79(1):73-7.

Wémeau-Stervinou L, Perez T, Murphy C, Polge AS, Wallaert B. Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia. Respir  Med. 2012 Apr;106(4):564-70.

Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D, Lacronique J, Monnet I, Reynaud-Gaubert M, Tazi A, Lebtahi R, Debray MP, Brauner  M, Dehoux M, Dornic Q, Aubier M, Mentré F, Duval X. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Eur Respir J. 2012 Mar;39(3):772-5.

Hachulla AL, Pontana F, Wemeau-Stervinou L, Khung S, Faivre JB, Wallaert B, Cazaubon JF, Duhamel A, Perez T, Devos P, Remy J, Remy-Jardin M. Krypton Ventilation Imaging Using Dual-Energy CT in Chronic Obstructive Pulmonary Disease Patients: Initial Experience. Radiology. 2012 Apr;263(1):253-9.

Lemyze M, Favory R, Alves I, Perez T, Mathieu D. Manual compression of the abdomen to assess expiratory flow limitation during mechanical ventilation. J Crit Care. 2012 Feb;27(1):37-44.

Moreau C, Brunaud-Danel V, Dallongeville J, Duhamel A, Laurier-Grymonprez L, de Reuck J, Wiart AC, Perez T, Richard F, Amouyel P, Bordet R, Defebvre L, Destée A, Devos D. Modifying effect of arterial hypertension on amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012 Feb;13(2):194-201.

Rivoisy C, Gérard L, Boutboul D, Malphettes M, Fieschi C, Durieu I, Tron F, Masseau A, Bordigoni P, Alric L, Haroche J, Hoarau C, Bérézné A, Carmagnat M, Mouillot G, Oksenhendler E, Just N et al,; DEFI study group. Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. J Clin Immunol. 2012 Feb;32(1):98-105.

Depontieu F, de Freitas Caires N, Gourcerol D, Giordano J, Grigoriu B, Delehedde M, Lassalle P. Development of monoclonal antibodies and ELISA specific for the mouse vascular endocan. J Immunol Methods. 2012. 378(1-2):88-94.

Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW, Scherpereel A, Cristaudo A, Pass HI, Nackaerts K, Rodríguez Portal JA, Schneider J, Muley T, Di Serio F, Baas P, Tomasetti M, Rai AJ, van Meerbeeck JP. Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis. J Clin Oncol. 2012. 30(13):1541-9.

Mikkelsen ME, Shah CV, Scherpereel A, Lanken PN, Lassalle P, Bellamy SL, Localio AR, Albelda SM, Meyer NJ, Christie JD. Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care. 2012 27(5):522.e11-7.

Cornelius A, Cortet-Rudelli C, Assaker R, Kerdraon O, Gevaert MH, Prévot V, Lassalle P, Trouillas J, Delehedde M, Maurage CA. Endothelial Expression of Endocan Is Strongly Associated with Tumor Progression in Pituitary Adenoma. Brain Pathol. 2012 ; 22(6):757-64.

Ampere A, Delhaes L, Soots J, Bart F, Wallaert B. Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Med Mycol. 2012 Aug;50(6):654-7.

Astoul P, Roca E, Galateau-Salle F, Scherpereel A. Malignant pleural mesothelioma: from the bench to the bedside. Respiration. 2012;83(6):481-93.

Blanquart C, Gueugnon F, Nguyen JM, Roulois D, Cellerin L, Sagan C, Perigaud C, Scherpereel A, Gregoire M. CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions. J Thorac Oncol. 2012 May;7(5):883-9.

Chenivesse C, Chang Y, Azzaoui I, Ait Yahia S, Morales O, Plé C, Foussat A, Tonnel AB, Delhem N, Yssel H, Vorng H, Wallaert B, Tsicopoulos A. Pulmonary CCL18 Recruits Human Regulatory T Cells. J Immunol, 2012, Jul 1;189(1):128-37.

Delhaes L, Monchy S, Fréalle E, Hubans C, Salleron J, Leroy S, Prevotat A, Wallet F, Wallaert B, Dei-Cas E, Sime-Ngando T, Chabé M, Viscogliosi E. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community–implications for therapeutic management. PLoS One. 2012;7(4):e36313.

Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O. Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev. 2012; 12(2):210-7.

Beucher J, Boëlle PY, Busson PF, Muselet-Charlier C, Clement A, Corvol H; French C F, Wallaert B et al, Modifier Gene Study Investigators. AGER -429T/C Is Associated with an  Increased Lung Disease Severity in Cystic Fibrosis. PLoS One. 2012;7(7):e41913.

Wallaert B, Wemeau-Stervinou L, Salleron J, Tillie-Leblond I, Perez T. Do we need exercise tests to detect gas exchange impairment in fibrotic idiopathic interstitial pneumonias? Pulm Med. 2012;2012:657180.

Hernández-Hernández F, Fréalle E, Caneiro P, Salleron J, Durand-Joly I, Accoceberry I, Bouchara JP, Wallaert B, Dei-Cas E, Delhaes L. Pneumocystis jirovecii colonization among cystic fibrosis patients: A French prospective multicenter study. J Clin Microbiol. 2012; 50(12):4107-10.

Herth FJ, Noppen M, Valipour A, Leroy S, Vergnon JM, Ficker JH, Egan JJ, Gasparini S, Agusti C, Holmes-Higgin D, Ernst A; Perez T et al, International VENT Study Group.  Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012 Jun;39(6):1334-42.

Caillaud DM, Lemoigne F, Carré P, Escamilla R, Chanez P, Pierre-Régis B, Isabelle CF, Gilles J, Christoph P, Perez T, Graziella B, Paillasseur JL, Roche N. Association between occupational exposure and the clinical characteritics of COPD. BMC Public Health. 2012 Apr 26;12(1):302.

Burgel PR, Roche N, Paillasseur JL, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Caillaud D; INITIATIVES BPCO Scientific Committee. Clinical COPD phenotypes identified by cluster analysis: validation with mortality. Eur Respir J. 2012 Aug;40(2):495-6.

Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, Assael BM, Barreto C, Drevinek P, Thomas M, Krivec U, Mei-Zahav M, Vibert JF, Clement A, Mehta A, Corvol H, Wallaert B et al; French CF Modifier Gene Study Investigators; European CF Registry Working Group. Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis. Orphanet J Rare Dis. 2012 Sep 7;7:64.

Hernández-Hernández F, Fréalle E, Caneiro P, Salleron J, Durand-Joly I, Accoceberry I, Bouchara JP, Wallaert B, Dei-Cas E, Delhaes L. Prospective multicenter study of Pneumocystis jirovecii colonization among cystic fibrosis patients in France. J Clin Microbiol. 2012 Dec;50(12):4107-10.

Wells AU, Behr J, Costabel U, Cottin V, Poletti V, Richeldi L; Wallaert B et al European IPF Consensus Group. Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good. Thorax. 2012 Nov;67(11):938-40.

Lorillon G, Bergeron A, Detourmignies L, Jouneau S, Wallaert B, Frija J, Tazi  A. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med. 2012 Nov 1;186(9):930-2.

Delourme J, Stervinou-Wemeau L, Salleron J, Grosbois JM, Wallaert B. Six-minute stepper test to assess effort intolerance in interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):107-12.

Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluña JJ, van der Molen T, Adamek L, Banik N. Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe. Prim Care Respir J. 2012 Sep;21(3):329-36.

Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP; European Lung Cancer Working Party. Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party. Lung Cancer. 2012 Sep;77(3):605-10.

Wémeau-Stervinou L, Perez T, Murphy C, Polge AS, Wallaert B. Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia. Respir Med. 2012 Apr;106(4):564-70.

Bondue B, De Henau O, Luangsay S, Devosse T, de Nadaï P, Springael JY, Parmentier M, Vosters O. The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo. PLoS One. 2012;7(6):e40043.

Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, Assael BM, Barreto C, Drevinek P, Thomas M, Krivec U, Mei-Zahav M, Vibert JF, Clement A, Mehta A, Corvol H; Prevotat A et al,French CF Modifier Gene Study Investigators. European CF Registry Working Group. Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis. Orphanet J Rare Dis. 2012 Sep 7;7:64.

Beucher J, Boëlle PY, Busson PF, Muselet-Charlier C, Clement A, Corvol H, Prevotat A et al; French C F Modifier Gene Study Investigators. AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis. PLoS One. 2012;7(7):e41913.

Cigna N, Farrokhi Moshai E, Brayer S, Marchal-Somme J, Wémeau-Stervinou L, Fabre A, Mal H, Lesèche G, Dehoux M, Soler P, Crestani B, Mailleux AA. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis. Am J Pathol. 2012 Dec;181(6):2126-37.

 

2011

Blanc AL, Jardin C, Faivre JB, Le Rouzic O, Do Cao C, Benhamed L, Ramon P, Fournier C. Pulmonary artery tumour-embolism diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Eur Respir J 2011;38:477-9.

Nseir S, Makris D, Mathieu D, Durocher A, Marquette CH. Intensive Care Unit-acquired infection as a side effect of sedation. Crit Care. 2010;14(2):R30.

Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler-Cataluña JJ, van der Molen T, Adamek L, Banik N. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011 Jan;105(1):57-66.

Scherpereel A, Berghmans T, Lafitte JJ, Colinet B, Richez M, Bonduelle Y, Meert AP, Dhalluin X, Leclercq N, Paesmans M, Willems L, Sculier JP; European Lung Cancer Working Party (ELCWP). Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study. Eur Respir J. 2011 Jan;37(1):129-35.

Moreau C, Gosset P, Kluza J, Brunaud-Danel V, Lassalle P, Marchetti P, Defebvre L, Destée A, Devos D. Deregulation of the hypoxia inducible factor-1α pathway in monocytes from sporadic amyotrophic lateral sclerosis patients. Neuroscience. 2011 Jan 13;172:110-7.

Akkök CA, Hervig T, Stamnesfet S, Nesthus I, Melve GK, Lassalle P, Bruserud O. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 2011 Nov;13(10):1259-68.

Hatfield KJ, Lassalle P, Leiva RA, Lindås R, Wendelboe Ø, Bruserud Ø. Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia. Hematology. 2011 Nov;16(6):351-6.

Boileau J, Mouillot G, Gérard L, Carmagnat M, Rabian C, Oksenhendler E, Pasquali JL, Korganow AS; Just N et al DEFI Study Group. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun. 2011 Feb;36(1):25-32.

Vince N, Boutboul D, Mouillot G, Just N, Peralta M, Casanova JL, Conley ME, Bories JC, Oksenhendler E, Malphettes M, Fieschi C; DEFI Study Group. Defects in the CD19 complex predispose to glomerulonephritis, as well as IgG1 subclass deficiency. J Allergy Clin Immunol. 2011 Feb;127(2):538-541

Tillie-Leblond I, Grenouillet F, Reboux G, Roussel S, Chouraki B, Lorthois C, Dalphin JC, Wallaert B, Millon L. Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J. 2011 Mar;37(3):640-7.

Hervier B, Uzunhan Y, Hachulla E, Benveniste O, Nunes H, Delaval P, Musset L, Dubucquoi S, Wallaert B, Hamidou M. Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies. Eur Respir J. 2011 Mar;37(3):714-7.

Gueugnon F, Leclercq S, Blanquart C, Sagan C, Cellerin L, Padieu M, Perigaud C, Scherpereel A, Gregoire M. Identification of novel markers for the diagnosis of malignant pleural mesothelioma. Am J Pathol. 2011 Mar;178(3):1033-42.

Leroy S, Perez T, Neviere R, Aguilaniu B, Wallaert B. Determinants of dyspnea and alveolar hypoventilation during exercise in cystic fibrosis: impact of inspiratory muscle endurance. J Cyst Fibros. 2011 May;10(3):159-65.

Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM; Wallaert B et al CAPACITY Study Group. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011 May 21;377(9779):1760-9.

Just N, Carpentier O, Brzezinki C, Steenhouwer F, Staumont-Sallé D. Severe hypersensitivity reaction as acute eosinophilic pneumonia and skin eruption induced by proguanil. Eur Respir J. 2011 Jun;37(6):1526-8.

Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluña JJ, van der Molen T, Adamek L, Banik N. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011 Jul;38(1):29-35.

Perotin JM, Jeanfaivre T, Thibout Y, Jouneau S, Lena H, Dutau H, Ramon P, Lorut C, Noppen M, Vergnon JM, Vallerand H, Merol JC, Marquette CH, Lebargy F, Deslee G. Endoscopic management of idiopathic tracheal stenosis. Ann Thorac Surg. 2011 Jul;92(1):297-301.

Blanc AL, Jardin C, Faivre JB, Le Rouzic O, Do Cao C, Benhamed L, Ramon P, Fournier C. Pulmonary artery tumour-embolism diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Eur Respir J. 2011 Aug;38(2):477-9.

Tillie-Leblond I, Germaud P, Leroyer C, Tétu L, Girard F, Devouassoux G, Grignet JP, Prudhomme A, Dusser D, Wallaert B. Allergic bronchopulmonary aspergillosis and omalizumab. Allergy. 2011 Sep;66(9):1254-6.

Lemyze M, Dharancy S, Nevière R, Wallaert B. Cardiopulmonary response to exercise in patients with liver cirrhosis and impaired pulmonary gas exchange. Respir Med. 2011 Oct;105(10):1550-6.

Paesmans M, Lafitte JJ, Lecomte J, Berghmans T, Efremidis A, Giner V, Van Cutsem O, Scherpereel A, Meert AP, Leclercq N, Van Houtte P, Sculier JP. Validation and comparison of several published prognostic systems for patients with small cell lung cancer. Eur Respir J. 2011 38(3):657-63 .

Morawiec E, Tillie-Leblond I, Pansini V, Salleron J, Remy-Jardin M, Wallaert B. Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses. Eur Respir J. 2011 Dec;38(6):1487-9.

Wallaert B, Talleu C, Wemeau-Stervinou L, Duhamel A, Robin S, Aguilaniu B. Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity. Respiration. 2011;82(6):501-8.

Nseir S, Zerimech F, Fournier C, Lubret R, Ramon P, Durocher A, Balduyck M. Continuous Control of Tracheal Cuff Pressure and Microaspiration of Gastric Contents in Critically Ill Patients. Am J Respir Crit Care Med. 2011: 184(9):1041-7.

Bérard E, Bongard V, Roche N, Perez T, Brouquières D, Taraszkiewicz D, Fievez  S, Denis F, Escamilla R, Ferrières J. Undiagnosed airflow limitation in patients  at cardiovascular risk. Arch Cardiovasc Dis. 2011 Dec;104(12):619-26.

Delattre C, Fournier C, Bouchindhomme B, Renaud F, Escande F, Ramon P, Copin MC. Endoscopic ultrasound guided transbronchial fine needle aspiration: a French  Department of Pathology’s 4-year experience. J Clin Pathol. 2011 Dec;64(12):1117-22.

Perez T. Is it really time to look at distal airways to improve asthma phenotyping and treatment? Eur Respir J. 2011 Dec;38(6):1252-4.

Azzaoui I, Ait Yahia S, Chang Y, Vorng H, Morales O, Fan Y, Delhem N, Ple C, Tonnel AB, Wallaert B, Tsicopoulos A. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects. Blood. 2011 118(13):3549-58.

Tonnel AB, Tillie-Leblond I, Attali V, Bavelele Z, Lagrange O. Predictive factors for evaluation of response to fluticasone propionate/salmeterol combination in severe COPD. Respir Med. 2011 Feb;105(2):250-8.

Benhamed L, Bellier J, Fournier C, Akkad R, Mathieu D, Kipnis E, Porte H. Postoperative ischemic bronchitis after lymph node dissection and primary lung cancer resection. Ann Thorac Surg. 2011 Feb;91(2):355-9.

Devosse T, Dutoit R, Migeotte I, de Nadai P, Imbault V, Communi D, Salmon I, Parmentier M. Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3. J Immunol. 2011; 187(3):1475-85.

Bondue B, Vosters O, de Nadai P, Glineur S, De Henau O, Luangsay S, Van Gool F, Communi D, De Vuyst P, Desmecht D, Parmentier M. ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. PLoS Pathog. 2011 Nov;7(11):e1002358.

Leroy G, Lambiotte F, Thévenin D, Lemaire C, Parmentier E, Devos P, Leroy O. Evaluation of “Candida score” in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care. 2011 Nov 30;1(1):50.

 

 

2010

Reikvam H, Hatfield KJ, Lassalle P, Kittang AO, Ersvaer E, Bruserud Ø. Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release. Expert Opin Investig Drugs. 2010 Feb;19(2):169-83.

Just N, Bautin N, Danel-Brunaud V, Debroucker V, Matran R, Perez T. The BORG dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J. 2010, 35(2):353-60.

Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Péchoux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma. Eur Respir J. 2010 Mar;35(3):479-95.

Barlési F, Balleyguier C, Besse B, Bonodeau F, Brenac F, Corneloup O, Dansin E, Ferretti G, Gaubert JY, Gervais R, Lacombe C, Loundou A, Moro-Sibilot D, Planchard D, Scherpereel A, Menu Y. Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors. Ann Oncol. 2010 Jan 11. [Epub ahead of print]

Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Roche N; on behalf of the Initiatives BPCO Scientific Committee.  Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J. 2010 Jan 14. [Epub ahead of print]

Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, Delehedde M, Copin MC, Lassalle P. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology. 2010 Jan;56(2):180-7

Paesmans M, Berghmans T, Dusart M, Garcia C, Hossein-Foucher C, Lafitte JJ, Mascaux C, Meert AP, Roelandts M, Scherpereel A, Terrones Munoz V, Sculier JP; European Lung Cancer Working Party, and on behalf of the IASLC Lung Cancer Staging Project. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project. J Thorac Oncol. 2010 May;5(5):612-9.

Morawiec E, Hachulla-Lemaire AL, Chabrol J, Rémy-Jardin M, Wallaert B. Venoatrial compression by lymphadenopathy in sarcoidosis. Eur Respir J. 2010 May;35(5):1188-91

Pourcet B, Pineda-Torra I, Derudas B, Staels B, Glineur C. SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR. J Biol Chem. 2010 Feb 26;285(9):5983-92.

Deswarte G, Richardson M, Polge AS, Pouwels S, Ennezat PV, Trochu JN, Wallaert B, Deklunder G, Le Tourneau T. Longitudinal Right Ventricular Function as a Predictor of Functional Capacity in Patients with Mitral Stenosis: An Exercise Echocardiographic Study. J Am Soc Echocardiogr. 2010 Apr 29. [Epub ahead of print]

Sarrazin S, Lyon M, Deakin JA, Guerrini M, Lassalle P, Delehedde M, Lortat-Jacob H. Characterization and binding activity of the chonDroitin / dermatan sulphate chain from Endocan, a soluble endothelial Proteoglycan. Glycobiology. 2010 Jun 24. [Epub ahead of print].

Torres D, Dieudonné A, Ryffel B, Vilain E, Si-Tahar M, Pichavant M, Lassalle P, Trottein F, Gosset P. Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells.  J Immunol. 2010 Jul 1;185(1):451-9.

Tillie-Leblond I, Grenouillet F, Reboux G, Roussel S, Chouraki B, Lorthois C,  Dalphin JC, Wallaert B, Millon L.  Hypersensitivity pneumonitis and metalworking fluids contaminated by Mycobacteria.  Eur Respir J. 2010 Aug 6.

Scherpereel A, Berghmans T, Lafitte JJ, Colinet B, Richez M, Bonduelle Y, Meert AP, Dhalluin X, Leclercq N, Paesmans M, Willems L; J.P. Sculier for the European Lung Cancer Working Party (ELCWP). Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study. Eur Respir J. 2010 Jun 7.[Epub ahead of print]

Behr J, Demedts M, Buhl R, Costabel U, Dekhuijzen RP, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Lankhorst I, Sardina M, Boissard G;  IFIGENIA study group. Lung function in idiopathic pulmonary fibrosis–extended analyses of the IFIGENIA trial. Respir Res. 2009 Oct 27;10:101.

Mouillot G, Carmagnat M, Gérard L, Garnier JL, Fieschi C, Vince N, Karlin L, Viallard JF, Jaussaud R, Boileau J, Donadieu J, Gardembas M, Schleinitz N, Suarez F, Hachulla E, Delavigne K, Morisset M, Jacquot S, Just N, Galicier L, Charron D, Debré P, Oksenhendler E, Rabian C; for the DEFI Study Group. B-Cell and T-Cell Phenotypes in CVID Patients Correlate with the Clinical Phenotype of the Disease. J Clin Immunol. 2010 Sep;30(5):746-755. Epub 2010 May 1.

Raiko I, Sander I, Weber DG, Raulf-Heimsoth M, Gillissen A, Kollmeier J, Scherpereel A, Brüning T, Johnen G. Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients. BMC Cancer. 2010 May 28;10:242.

van Meerbeeck JP, Scherpereel A, Surmont VF, Baas P. Malignant pleural mesothelioma: The standard of care and challenges for future management. Crit Rev Oncol Hematol. 2010 May 11. [Epub ahead of print].

Chang Y, de Nadai P, Azzaoui I, Morales O, Delhem N, Vorng H, Tomavo S, Ait Yahia S, Zhang G, Wallaert B, Chenivesse C, Tsicopoulos A. The chemokine CCL18 generates adaptive regulatory T cells from memory CD4+ T cells of healthy but not allergic subjects. FASEB J. 2010 Aug 11. [Epub ahead of print]

 

2009

Gilet J, Chang Ying, Chenivesse C, Legendre B, Vorng H, Duez C, Wallaert B, Porte H, Senechal S, Tsicopoulos A. Role of CCL17 in the generation of cutaneous inflammatory reactions in hu-PBMC-SCID mice grafted with human skin, J Invest Dermatol, 2009, 129(4):879-90.

Maurage CA, Adam E, Minéo JF, Sarrazin S, Debunne M, Siminski RM, Baroncini M, Lassalle P, Blond S, Delehedde M.Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol. 2009 68(6):633-41.

Grigoriu B, Chahine B, Zerimech F, Grégoire M, Balduyck M, Copin MC, Devos P, Lassalle P, Scherpereel A. Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma. Clin Biochem. 2009. 42(10-11):1046-50.

Taront S, Dieudonné A, Blanchard S, Jeannin P, Lassalle P, Delneste Y, Gosset P. Implication of scavenger receptors in the interactions between diesel exhaust particles and immature or mature dendritic cells. Part Fibre Toxicol. 2009 Mar 13;6:9.

Estrella C, Rocks N, Paulissen G, Quesada-Calvo F, Noël A, Vilain E, Lassalle P, Tillie-Leblond I, Cataldo D, Gosset P. Role of A disintegrin and metalloprotease-12 in neutrophil recruitment induced by airway epithelium. Am J Respir Cell Mol Biol. 2009. 41(4):449-58.

Moreau C, Gosset P, Brunaud-Danel V, Lassalle P, Degonne B, Destee A, Defebvre L, Devos D. CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients. Amyotroph Lateral Scler. 2009. 10(3):175-81.

Hatfield K, Øyan AM, Ersvaer E, Kalland KH, Lassalle P, Gjertsen BT, Bruserud Ø. Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators. Br J Haematol. 2009 Jan;144(1):53-68.

Ryningen A, Stapnes C, Lassalle P, Corbascio M, Gjertsen BT, Bruserud O. A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid. Leuk Res. 2009 Jun;33(6):779-87.

Grigoriu BD, Grigoriu C, Chahine B, Gey T, Scherpereel A. Clinical utility of diagnostic markers for malignant pleural mesothelioma. Monaldi Arch Chest Dis. 2009 Mar;71(1):31-8.

Grigoriu B, Scherpereel A. Screening for malignant mesothelioma–looking for the holy grail. Am J Respir Crit Care Med. 2009 May 1;179(9):851.

Vandermeers F, Hubert P, Delvenne P, Mascaux C, Grigoriu B, Burny A, Scherpereel A, Willems L. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clin Cancer Res. 2009 Apr 15;15(8):2818-28.

Grigoriu BD, Chahine B, Vachani A, Gey T, Conti M, Sterman DH, Marchandise G, Porte H, Albelda SM, Scherpereel A. Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment. Am J Respir Crit Care Med. 2009, 179(10):950-4.

Behr J, Demedts M, Buhl R, Costabel U, Dekhuijzen RP, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Lankhorst I, Sardina M, Boissard G; IFIGENIA study group. Lung function in idiopathic pulmonary fibrosis–extended analyses of the IFIGENIA trial. Respir Res. 2009 Oct 27;10:101.

Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet MA, Le Roux E, Lemonnier L, Gutierrez C, Vincent V, Fauroux B, Rottman M, Guillemot D, Gaillard JL; Jean-Louis Herrmann; Wallaert B for the OMA Group. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol. 2009 Dec;47(12):4124-8.

King TE Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM; Wallaert B for the INSPIRE Study Group. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009 Jul 18;374(9685):222-8

Hubert D, Le Roux E, Lavrut T, Wallaert B, Scheid P, Manach D, Grenet D, Sermet-Gaudelus I, Ramel S, Cracowski C, Sardet A, Wizla N, Deneuville E, Garraffo R. Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis. Antimicrob Agents Chemother. 2009 Sep;53(9):3650-6.

Holmberg K, Tonnel AB, Dreyfus I, Olsson P, Cougnard J, Mesbah K, Devillier P. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis. Allergy. 2009 Nov;64(11):1663-70.

Perez T, Arnould B, Grosbois JM, Bosch V, Guillemin I, Bravo ML, Brun M, Tonnel AB; TIPHON Study Group. Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009;4:9-18.

 

2008

Adam E, Sarrazin S, Landolfi C, Motte V, Lortat-Jacob H, Lassalle P, Delehedde M. Efficient long-term and high-yielded production of a recombinant proteoglycan in eukaryotic HEK293 cells using a membrane-based bioreactor. Biochem Biophys Res Commun, 2008, 369(2):297-302.

Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF Jr, Lafitte JJ, Sculier JP; European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol, 2008, 3(1):6-12.

Berghmans T, Gourcerol D, Lafitte JJ, Kotsori K, Paesmans M, Scherpereel A, Leclercq N, Sculier JP; for the European Lung Cancer Working Party. Mitomycin plus vinorelbine salvage chemotherapy in non-small cell lung cancer: A prospective study. Lung Cancer, 2008. 61(3):378-84.

Carré PC, Roche N, Neukirch F, Radeau T, Perez T, Terrioux P, Ostinelli J, Pouchain D, Huchon G. The Effect of an Information Leaflet upon Knowledge and Awareness of COPD in Potential Sufferers. A Randomized Controlled Study. Respiration, 2008, 76(1):53-60.

Catlow KR, Deakin JA, Wei Z, Delehedde M, Fernig DG, Gherardi E, Gallagher JT, Pavão MS, Lyon M. Interactions of Hepatocyte Growth Factor/Scatter Factor with Various Glycosaminoglycans Reveal an Important Interplay between the Presence of Iduronate and Sulfate Density. J Biol Chem, 2008, 283(9):5235-5248.

Depontieu F, Grigoriu BD, Scherpereel A, Adam E, Delehedde M, Gosset P, Lassalle P. Loss of Endocan tumorigenic properties after alternative splicing of exon 2. BMC Cancer, 2008, 8:14.

Ferrari F, Liu ZH, Lu Q, Becquemin MH, Louchahi K, Aymard G, Marquette CH, Rouby JJ. Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers. Intensive Care Med, 2008.

Grigoriu BD, Scherpereel A. Diagnostic value of soluble mesothelin in malignant mesothelioma. Thorax, 2008, 63(1):87-88.

Plé C, Duez C. Toll-like receptor expressing cells for antiallergy compound screening. Expert Opinion on drug Discovery, 2008, 3(6)629-641.

Roche N, Dalmay F, Perez T, Kuntz C, Vergnenègre A, Neukirch F, Giordanella JP, Huchon G. Impact of chronic airflow obstruction in a working population. Eur Respir J, 2008, 31(6):1227-1233.

Sapede C, Gauvrit A, Barbieux I, Padieu M, Cellerin L, Sagan C, Scherpereel A, Dabouis G, Grégoire M. Aberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cells. Cancer Sci, 2008, 99(3):590-594.

Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D, Humbert M, Couderc LJ, Wallaert B, Cadranel J. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.Thorax, 2008, 63(1):53-59.

Tsicopoulos A, Duez C, Saxon A. Environmental Factors in IgE production. Allergy and Allergic Diseases (Second Edition). Blackwell publishing, 2008 Chapter 7

Tonnel AB, Pouwels-Frys S, Tillie-Leblond I.Allergic bronchopulmonary aspergillosis. Allergy and Allergic Diseases (Second Edition). Blackwell publishing, 2008 Chapter 82

Cette note est également disponible en: Anglais